Contraception Continuing Medical Education

Episodes 1-15 of 15

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Jeffrey T. Jensen, MD, MPH

    Peer

  6

  

  RestartResume

  Applying Clinical Trial Data on Newer CHCs into Real-World Patient Care

  Applying Clinical Trial Data on Newer CHCs into Real-World Patient Care

  0.25 credits

• • 

    

    David L. Eisenberg, MD, MPH, FACOG

    Peer

  • 

    

    David J. Portman, MD

    Peer

  5

  

  RestartResume

  Contraception: Focus on Vaginal pH Modulation

  Contraception: Focus on Vaginal pH Modulation

  0.25 credits

• • 

    

    David L. Eisenberg, MD, MPH, FACOG

    Peer

  • 

    

    Patty Cason

    Peer

  • 

    

    David J. Portman, MD

    Peer

  11

  

  RestartResume

  A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator

  A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator

  1.00 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Barbara Dehn

    Peer

  12

  

  RestartResume

  Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability

  Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Andrew M. Kaunitz, MD, FACOG

    Peer

  22

  

  RestartResume

  New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)

  New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Anita L. Nelson, MD

    Peer

  27

  

  RestartResume

  The Evolution of Estrogen in Contraception—From E1 to E4

  The Evolution of Estrogen in Contraception—From E1 to E4

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    David J. Portman, MD

    Peer

  15

  

  RestartResume

  Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch

  Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch

  0.25 credits

• • 

    

    William Mencia, MD, FACEHP, CHCP

    Peer

  • 

    

    Stephen M. Cohen, MD, FACOG

    Peer

  • 

    

    Sateria Venable

    Peer

  22

  

  RestartResume

  New Directions in the Management of Uterine Fibroids

  New Directions in the Management of Uterine Fibroids

  0.50 credits

• • 

    

    David J. Portman, MD

    Peer

  9

  

  RestartResume

  The Changing Landscape of Contraceptive Trials: Recent Approvals and Future Directions

  The Changing Landscape of Contraceptive Trials: Recent Approvals and Future Directions

  0.50 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Thomas D. Kimble, MD

    Peer

  11

  

  RestartResume

  Expanding Choices in Combined Hormonal Contraceptives: The Creeping Pearl Index

  Expanding Choices in Combined Hormonal Contraceptives: The Creeping Pearl Index

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Kenneth J. Moise Jr., MD

    Peer

  10

  

  RestartResume

  Hemolytic Disease of the Fetus and Newborn: Cutting Edge Strategies for Diagnosis and Management

  Hemolytic Disease of the Fetus and Newborn: Cutting Edge Strategies for Diagnosis and Management

  0.25 credits

• • 

    

    David L. Eisenberg, MD, MPH, FACOG

    Peer

  • 

    

    David J. Portman, MD

    Peer

  19

  

  RestartResume

  A New Era Begins in Contraception: The Vaginal Gel pH Modulator

  A New Era Begins in Contraception: The Vaginal Gel pH Modulator

  0.25 credits

• • 

    

    William Mencia, MD, FACEHP, CHCP

    Peer

  • 

    

    Sateria Venable

    Peer

  14

  

  RestartResume

  Health Disparities in the Management of Uterine Fibroids

  Health Disparities in the Management of Uterine Fibroids

  0.25 credits

• • 

    

    Anita L. Nelson, MD

    Peer

  • 

    

    David J. Portman, MD

    Peer

  12

  

  RestartResume

  Expanding Choices in Combined Hormonal Contraceptives—Seeing Beyond LARCs

  Expanding Choices in Combined Hormonal Contraceptives—Seeing Beyond LARCs

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Anita L. Nelson, MD

    Peer

  14

  

  RestartResume

  Expanding Contraceptive Choices Beyond Long-Acting Reversible Methods

  Expanding Contraceptive Choices Beyond Long-Acting Reversible Methods

  0.25 credits